Tracy L. Stup

Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide

Robert W. Buckheit, T L Kinjerski, Valerie Fliakas-Boltz et al. · Antimicrobial Agents and Chemotherapy · 1995 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Structural Analogues of the Calanolide Anti-HIV Agents. Modification of the <i>trans</i>-10,11-Dimethyldihydropyran-12-ol Ring (Ring C)

David E. Zembower, Shuyuan Liao, Michael T. Flavin et al. · Journal of Medicinal Chemistry · 1997 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Unique Anti-Human Immunodeficiency Virus Activities of the Nonnucleoside Reverse Transcriptase Inhibitors Calanolide A, Costatolide, and Dihydrocostatolide

Robert W. Buckheit, E. Lucile White, Valerie Fliakas-Boltz et al. · Antimicrobial Agents and Chemotherapy · 1999 · 66 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups

R W Buckheit, Walter J. Decker, J. Alan Roberson et al. · Antiviral Research · 1995 · 63 citations

Life Sciences, Infectious Diseases, Microbiology +14

In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI

Ze‐Qi Xu, Robert W. Buckheit, Tracy L. Stup et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 44 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12